FDA Adverse Event Injury Summary report: N

SILASTIC VARIFIL MAMMARY IMPLANT, H.P., INFLATABLE

MDR report key: 46570 · Received October 31, 1996

Report

Report Number
1816403-1996-00227
Event Type
Injury
Date Received
October 31, 1996
Date of Event
August 1, 1996
Report Date
October 3, 1996
Manufacturer
DOW CORNING CORP.
Product Code
FWM
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

METHOD: 86C DIMENSIONAL MEASUREMENT; 86D MICROSCOPIC EXAMINATION. RESULTS: 100A LOSS OF SHELL INTEGRITY, ENVELOPE SLIT; 100B CREASE LINES; 100C SLIGHT AMBER COLOR; 100E FOREIGN MATERIAL; 100H LOSS OF SHELL INTEGRITY, EVELOPE TEAR. DEVICE 1 OF 2 CONCLUSIONS: 68 FOREIGN MATERIAL LIKELY RESIDUAL SALINE; SLIT CAUSED BY SHARP OBJECT CONTACT; COLOR WITHIN SPECIFICATIONS; CREASES AND WEAR RESULT OF FOLDING ACTION IN-VIVO. DEVICE 2 OF 2 CONCLUSIONS: 68 FOREIGN MATERIAL LIKELY RESIDUAL SALINE; CAUSE OF TEAR UNDETERMINED; COLOR WITHIN SPECIFICATIONS.

Additional Manufacturer Narrative · 1

METHOD: 86C DIMENSIONAL MEASUREMENT; 86D MICROSCOPIC EXAMINATION. RESULTS: 100A LOSS OF SHELL INTEGRITY, ENVELOPE SLIT; 100B CREASE LINES; 100C SLIGHT AMBER COLOR; 100E FOREIGN MATERIAL; 100H LOSS OF SHELL INTEGRITY, ENVELOP TEAR. DEVICE 1 OF 2 CONCLUSIONS: 68 FOREIGN MATERIAL LIKELY RESIDUAL SALINE; SLIT CAUSED BY SHARP OBJECT CONTACT; COLOR WITHIN SPECIFICATIONS; CREASES AND WEAR RESULT OF FOLDING ACTION IN-VIVO. DEVICE 2 OF 2 CONCLUSIONS: 68 FOREIGN MATERIAL LIKELY RESIDUAL SALINE; CAUSE OF TEAR UNDETERMINED; COLOR WITHIN SPECIFICATIONS.

Description of Event or Problem · 1

PHYSICIAN'S NOTE SHOWS PT RECEIVED BREAST IMPLANTS ON 5/16/79. IN 8/95, PT HAD DEFLATION OF LEFT IMPLANT; THERFORE, ON 9/4/96 PT HAD EXCISION OF THE DEFLATED LEFT AND INTACT RIGHT IMPLANTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SILASTIC VARIFIL MAMMARY IMPLANT, H.P., INFLATABLE Implant MAMMARY IMPLANT, SALINE FILL FWM DOW CORNING CORP. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 42 YR Required Intervention